Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14511328rdf:typepubmed:Citationlld:pubmed
pubmed-article:14511328lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C0291573lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C0038220lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:14511328lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:14511328pubmed:issue6lld:pubmed
pubmed-article:14511328pubmed:dateCreated2003-9-26lld:pubmed
pubmed-article:14511328pubmed:abstractTextIt is in dispute whether caspase 3 contributes to status epilepticus (SE)-induced cell loss. We hypothesized that caspase 3-mediated cell death continues beyond the acute phase of SE. We induced SE with either kainic acid or electrical stimulation of the amygdala in Wistar and Sprague-Dawley rats. Caspase 3 immunohistochemistry, Western blot analysis and enzyme activity measurements were used to determine cellular localization and the time course of caspase 3 expression and activation. Immunohistochemistry indicated that caspase 3 protein expression increased following SE, peaking at 16-24 h. Cleavage of procaspase 3 to active fragments (p20-17) was detected 2-7 days after SE. Caspase 3 enzyme activity was elevated at 8 h and further increased up to 19.4-fold at 7 days following SE. Activation of caspase 3 after SE occurred in the hippocampus and the extrahippocampal temporal lobe but not in the thalamus. Caspase 3-immunoreactive cells represented only a minority of degenerating cells as assessed by Fluoro-Jade B and TUNEL staining. Analysis of double-labelled sections indicated that active caspase 3 was located in astrocytes rather than neurons or microglia. There was increased caspase 3 expression in both rat strains, and it was independent of the method used to induce SE. These data demonstrate that caspase 3 contributes to the cell death occurring within the first week after SE, but in only a small proportion of degenerating cells. These results suggest that, contrary to expectations, caspase 3 inhibitors would have only limited benefits in the treatment of SE.lld:pubmed
pubmed-article:14511328pubmed:languageenglld:pubmed
pubmed-article:14511328pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:citationSubsetIMlld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14511328pubmed:statusMEDLINElld:pubmed
pubmed-article:14511328pubmed:monthSeplld:pubmed
pubmed-article:14511328pubmed:issn0953-816Xlld:pubmed
pubmed-article:14511328pubmed:authorpubmed-author:PitkänenAslaAlld:pubmed
pubmed-article:14511328pubmed:authorpubmed-author:PirttiläTerhi...lld:pubmed
pubmed-article:14511328pubmed:authorpubmed-author:LukasiukKatar...lld:pubmed
pubmed-article:14511328pubmed:authorpubmed-author:NarkilahtiSus...lld:pubmed
pubmed-article:14511328pubmed:authorpubmed-author:TuunanenJarkk...lld:pubmed
pubmed-article:14511328pubmed:issnTypePrintlld:pubmed
pubmed-article:14511328pubmed:volume18lld:pubmed
pubmed-article:14511328pubmed:ownerNLMlld:pubmed
pubmed-article:14511328pubmed:authorsCompleteYlld:pubmed
pubmed-article:14511328pubmed:pagination1486-96lld:pubmed
pubmed-article:14511328pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:meshHeadingpubmed-meshheading:14511328...lld:pubmed
pubmed-article:14511328pubmed:year2003lld:pubmed
pubmed-article:14511328pubmed:articleTitleExpression and activation of caspase 3 following status epilepticus in the rat.lld:pubmed
pubmed-article:14511328pubmed:affiliationA.I. Virtanen Institute for Molecular Sciences, University of Kuopio, PO Box 1627, FIN-70 211 Kuopio, Finland.lld:pubmed
pubmed-article:14511328pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14511328pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:14511328pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14511328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14511328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14511328lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14511328lld:pubmed